Pathios Therapeutics Raises $25M in First Close of Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
📰 Pathios Therapeutics News
Pathios Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pathios Therapeutics. Real-time updates on events, politics, business and more.
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...
Source: prnewswire.com
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.
Source: insidermonkey.com
Pathios Therapeutics Awarded Innovate UK Grant to Evaluate First-in-Class Immunotherapy Approach in Models of Malignant Brain Cancer
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...
United Kingdom Stuart Hughes Alan Mcintyre Tim Brons Professor Of Faculty Medicine Health Sciences Nottingham Trent University
Source: prnewswire.com
Pathios Therapeutics Unveils PTT-4256, a Highly Potent and Selective Inhibitor of GPR65, in Presentation at American Association for Cancer Research (AACR) Annual Meeting 2023
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...
United States United Kingdom Stuart Hughes Tim Brons American Association For Cancer Research Innovation Centre On Milton Park
Source: prnewswire.com
ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023
/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...
United States Orange County Convention Center United Kingdom Tom Mccarthy James Westcott Prnewswire Thirtyfivebio
Source: prnewswire.com
Pathios Therapeutics Appoints Jeanmarie Guenot, Ph.D., as Non-Executive Director
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on developing first-in-class therapies for cancer, today announced that...
United Kingdom Tim Brons Jeanmarie Guenot Stuart Hughes Prnewswire Pathios Therapeutics Limited Innovation Centre On Milton Park
Source: prnewswire.com
Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics
Financing led by Brandon Capital from its newly established UK operation; Forbion and Atlas Venture co-led the round USD68M series A will enable London-based...
Source: prnewswire.com